欧盟委员会发布兽药GMP实施条例(EU)2025/2091与(EU)2025/2154
GMP for Veterinary Products: Implementing Regulations published
欧盟委员会于2025年10月在《欧盟官方公报》发布两项兽药GMP实施条例,分别为针对成品的(EU)2025/2091和针对用作起始物料的活性物质的(EU)2025/2154。两项条例将于2026年7月16日生效,取代EudraLex第4卷现行的兽药及其活性物质GMP规定。欧盟委员会同时发布对应关系表,说明新规与现行GMP框架的衔接。
材料梳理了两项兽药GMP实施条例的发布、2026年7月16日生效安排,以及与人用GMP框架的对应关系表。
The European Commission published new implementing Regulations for veterinary medicines good manufacturing practice (GMP) in the Official Journal in October 2025: Commission Implementing Regulation (EU) 2025/2091 (for GMP of finished products) Commission Implementing Regulation (EU) 2025/2154 (for GMP of active substances used as starting materials).The new Implementing Regulations define the Good Manufacturing Practice (GMP) requirements introduced under Regulation (EU) 2019/6 on veterinary medicinal products and will take effect on 16 July 2026. They will replace the current GMP provisions for veterinary medicinal products and their active substances set out in EudraLex Volume 4, which are currently aligned with the GMP framework for human medicinal products. This alignment will continue, although the new veterinary GMP requirements will have their own dedicated legal basis under the veterinary legislation. To support stakeholders, the European Commission has issued tables of correspondence that map each Implementing Regulation to the existing GMP requirements for veterinary medicinal products and active substances, providing clear guidance on how the new rules relate to the current framework.
来源:ECA GMP News · gmp-compliance.org